Skip to content

CG Oncology CGON Interest Paid

Interest Paid at other companies

Pfizer logo
PfizerPFE
$293M-17.0%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$465.75M-2.5%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$20.12M+29.0%
Celcuity logo
CelcuityCELC
$5.89M+147%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$1.75M+600%

Other financials

Income statement

See full
Revenue$1.1M+1,983%
Operating income-$66.4M-57.3%
Net income-$60.2M-74.7%
EPS (diluted)-$0.71-57.8%

Balance sheet

See full
Cash & equivalents$33.7M-18.7%
Total debt$7.6M+631%
Total equity$1.1B+54.9%
Total assets$1.1B+55.9%

Cash flow

See full
Operating cash flow-$56.9M-94.5%
CapEx$304.0K+1,800%
Free cash flow-$57.2M-95.4%

Valuation

See full
Market cap$5.8B+206%

Profitability

See full
Operating margin-4,239%-1,872pp
Net margin-3,682.6%-1,601pp
FCF margin-3,163.8%-1,351pp

Returns & leverage

See full
Return on equity-20.8%+7.1pp
Debt / equity0.0×
Current ratio31.3×+0.3×

Where this comes from

Reported directly by CG Oncology in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: CG Oncology’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about CG Oncology's interest paid.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CG Oncology's interest paid?
CG Oncology (CGON) reported interest paid of $47K in Q1 2026.
How has CG Oncology's interest paid changed year-over-year?
CG Oncology's interest paid increased by 82.5% year-over-year, from $25.75K to $47K.
What does interest paid mean?
Supplemental disclosure of total cash interest paid on all debt and lease obligations during the period.